Kathryn Hayashi brings more than 20 years of leadership experience spanning life sciences, nuclear medicine, quantum technologies and deep-tech commercialization. She connects research, industry, government and investment to help translate scientific advances into practical and economic benefits.

At the Quantum Algorithms Institute, Kathryn is guiding the organization’s next phase, including the development of the BC Quantum Gateway and BC Quantum Opportunity Fund to strengthen collaboration and advance quantum innovation in British Columbia.

Previously, Kathryn served as President and CEO of TRIUMF Innovations, Founding CFO of the Centre for Drug Research and Development (now adMare BioInnovations), and Co-Lead of the Canadian Medical Isotope Ecosystem. Across her career, she has helped mobilize more than $200 million in public and private investment.